TI
RVNC

Trexquant Investment’s Revance Therapeutics, Inc. RVNC Stock Holding History

Trexquant Investment’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,469
Closed -$132K – 1914
2024
Q3 		$132K Buy
+25,469
New +$127K ﹤0.01% 1466
2024
Q2 		– Sell
-101,899
Closed -$501K – 1924
2024
Q1 		$501K Buy
101,899
+36,140
+55% +$214K 0.01% 1146
2023
Q4 		$578K Buy
+65,759
New +$539K 0.01% 1022
2023
Q2 		– Sell
-10,655
Closed -$343K – 1882
2023
Q1 		$343K Sell
10,655
-5,770
-35% -$180K 0.01% 1146
2022
Q4 		$303K Buy
+16,425
New +$376K 0.01% 1104
2022
Q2 		– Sell
-16,814
Closed -$328K – 1943
2022
Q1 		$328K Buy
+16,814
New +$255K 0.02% 962
2018
Q3 		– Sell
-14,499
Closed -$398K – 1244
2018
Q2 		$398K Sell
14,499
-7,688
-35% -$231K 0.03% 608
2018
Q1 		$683K Buy
22,187
+15,367
+225% +$494K 0.05% 532
2017
Q4 		$244K Buy
+6,820
New +$196K 0.03% 837
2017
Q3 		– Sell
-8,766
Closed -$231K – 1085
2017
Q2 		$231K Buy
+8,766
New +$195K 0.06% 602
2016
Q2 		– Sell
-48,002
Closed -$838K – 1153
2016
Q1 		$838K Buy
48,002
+22,902
+91% +$466K 0.1% 355
2015
Q4 		$857K Sell
25,100
-15,200
-38% -$527K 0.08% 454
2015
Q3 		$1.2M Buy
40,300
+10,400
+35% +$316K 0.1% 347
2015
Q2 		$956K Sell
29,900
-13,400
-31% -$345K 0.11% 346
2015
Q1 		$897K Buy
43,300
+25,500
+143% +$441K 0.09% 421
2014
Q4 		$301K Buy
+17,800
New +$311K 0.05% 689

Other funds holding RVNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Trexquant Investment's RVNC Position: Q4 2024 in Review

Trexquant Investment sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2024, closing a stake of 25,469 shares — an estimated $132K sold.

Trexquant Investment first reported a position in RVNC in Q4 2014 and held it in 16 quarters. The position peaked at $1.2M in Q3 2015. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • Trexquant Investment reported no remaining Revance Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • Trexquant Investment sold 25,469 Revance Therapeutics, Inc. shares in Q4 2024, an estimated $132K.
  • Trexquant Investment first reported a position in Revance Therapeutics, Inc. in Q4 2014 and held it in 16 quarters.
  • Trexquant Investment's Revance Therapeutics, Inc. position peaked at $1.2M in Q3 2015.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on Trexquant Investment's 13F filing for Q4 2024, filed 12 Feb 2025.